Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ferdinando Clarelli

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Genes|November 27, 2025
Long Non-Coding RNAs in Multiple Sclerosis-Differential Expression and Functional ImplicationsKaalindi Misra, Aishwary Nerkar, Ferdinando Clarelli, et al.
Frontiers in Neurology|March 10, 2022
<i>BDNF</i> Val66Met Polymorphism Is Associated With Motor Recovery After Rehabilitation in Progressive Multiple Sclerosis PatientsAntonino Giordano, Ferdinando Clarelli, Miryam Cannizzaro, et al.
Genes|November 24, 2022
Exploring the Association of HLA Genetic Risk Burden on Thalamic and Hippocampal Atrophy in Multiple Sclerosis PatientsSilvia Santoro, Ferdinando Clarelli, Paolo Preziosa, et al.
Biotechniques|July 18, 2012
AMDA 2.13: A major update for automated cross-platform microarray data analysisDimos Kapetis, Ferdinando Clarelli, Federico Vitulli, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 25, 2020
Early evidence of disease activity during fingolimod predicts medium-term inefficacy in relapsing-remitting multiple sclerosisLaura Ferrè, Andrea Mogavero, Ferdinando Clarelli, et al.
Pharmacogenomics|January 24, 2022
Transcriptional effects of fingolimod treatment on peripheral T cells in relapsing remitting multiple sclerosis patientsGiacomo Sferruzza, Ferdinando Clarelli, Elisabetta Mascia, et al.
European Journal of Neurology|April 17, 2021
Assessment of the genetic contribution to brain magnetic resonance imaging lesion load and atrophy measures in multiple sclerosis patientsFerdinando Clarelli, Maria Assunta Rocca, Silvia Santoro, et al.
European Journal of Neurology|June 30, 2025
Contribution of Polygenic Scores to Progression Independent of Relapse Activity in Multiple SclerosisFerdinando Clarelli, Melissa Sorosina, Antonino Giordano, et al.
Journal of Neurology|June 27, 2022
Early use of fingolimod is associated with better clinical outcomes in relapsing-remitting multiple sclerosis patientsMiryam Cannizzaro, Laura Ferré, Ferdinando Clarelli, et al.
Scientific Reports|April 7, 2020
Author Correction: Next Generation Sequencing of Pooled Samples: Guideline for Variants' FilteringSantosh Anand, Eleonora Mangano, Nadia Barizzone, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Genes|November 27, 2025
Long Non-Coding RNAs in Multiple Sclerosis-Differential Expression and Functional ImplicationsKaalindi Misra, Aishwary Nerkar, Ferdinando Clarelli, et al.
Frontiers in Neurology|March 10, 2022
<i>BDNF</i> Val66Met Polymorphism Is Associated With Motor Recovery After Rehabilitation in Progressive Multiple Sclerosis PatientsAntonino Giordano, Ferdinando Clarelli, Miryam Cannizzaro, et al.
Genes|November 24, 2022
Exploring the Association of HLA Genetic Risk Burden on Thalamic and Hippocampal Atrophy in Multiple Sclerosis PatientsSilvia Santoro, Ferdinando Clarelli, Paolo Preziosa, et al.
Biotechniques|July 18, 2012
AMDA 2.13: A major update for automated cross-platform microarray data analysisDimos Kapetis, Ferdinando Clarelli, Federico Vitulli, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 25, 2020
Early evidence of disease activity during fingolimod predicts medium-term inefficacy in relapsing-remitting multiple sclerosisLaura Ferrè, Andrea Mogavero, Ferdinando Clarelli, et al.
Pharmacogenomics|January 24, 2022
Transcriptional effects of fingolimod treatment on peripheral T cells in relapsing remitting multiple sclerosis patientsGiacomo Sferruzza, Ferdinando Clarelli, Elisabetta Mascia, et al.
European Journal of Neurology|April 17, 2021
Assessment of the genetic contribution to brain magnetic resonance imaging lesion load and atrophy measures in multiple sclerosis patientsFerdinando Clarelli, Maria Assunta Rocca, Silvia Santoro, et al.
European Journal of Neurology|June 30, 2025
Contribution of Polygenic Scores to Progression Independent of Relapse Activity in Multiple SclerosisFerdinando Clarelli, Melissa Sorosina, Antonino Giordano, et al.
Journal of Neurology|June 27, 2022
Early use of fingolimod is associated with better clinical outcomes in relapsing-remitting multiple sclerosis patientsMiryam Cannizzaro, Laura Ferré, Ferdinando Clarelli, et al.
Scientific Reports|April 7, 2020
Author Correction: Next Generation Sequencing of Pooled Samples: Guideline for Variants' FilteringSantosh Anand, Eleonora Mangano, Nadia Barizzone, et al.
Pageof 5